Myrtecaine

This classification denotes an anesthetic agent with the molecular formula C17H31NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9902116282, chemically known as 2-(2-(6,6-dimethylbicyclo(3.1.1)hept-2-en-2-yl)ethoxy)-n,n-diethylethanamine but generally known as myrtecaine, which bears US NIH Compound Identifier 71851. European Medicines Agency schedules Myrtecaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09102MIG. The term MYRTECAINE is an International Non-Proprietary Name. MYRTECAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule myrtecaine under HS 29221980 and SITC 51461. As of Q4 2014, MYRTECAINE remains the US FDA Preferred Term for this commodity. Myrtecaine bears US NLM identifiers UMLS ID C0163061 and NCI Concept Code C90653. SMILES: O(CCC1=CCC2C(C1C2)(C)C)CCN(CC)CC.